Bruker Spatial Genomics

Executive Summary

Bruker Spatial Genomics is a pioneering biotechnology company that enables direct, in situ visualization of the 3D genome in single cells through its proprietary PaintScape™ platform, powered by jebFISH™ technology. This innovative approach allows researchers to perform multiplexed imaging of genome architecture and chromosomal structure at unprecedented single-cell and single-chromosome resolution. By elucidating the links between genome organization, cell programming, and disease mechanisms, the company aims to transform understanding in areas like cancer research. Founded in 2022 and based in San Diego, Bruker Spatial Genomics operates as a private entity, leveraging its cutting-edge technology to address critical gaps in spatial genomics. The platform's ability to provide detailed insights into nuclear organization positions it as a key enabler for both basic research and translational applications, with potential to accelerate discoveries in gene regulation, development, and disease pathology.

Upcoming Catalysts (preview)

• Q3 2026Commercial Launch of PaintScape™ Platform70% success
• Q4 2026Strategic Partnership with Major Research Institution or Pharma60% success
• Q2 2026Publication of Landmark Study Using jebFISH™ Technology80% success